Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Monocytosis Causes and Diagnostic Approach

Introduction to Monocytosis

  • Monocytosis has two major categories of causes: reactive (benign) conditions and clonal hematologic malignancies, particularly chronic myelomonocytic leukemia (CMML), which must be systematically excluded in cases of persistent elevation 1

Reactive Causes

  • Chronic infections, such as tuberculosis and bacterial endocarditis, are common infectious causes of monocytosis 1
  • Adult-onset Still's disease presents with marked leukocytosis, including monocytosis, often with white blood cell counts >15×10⁹ cells/L 2
  • Inflammatory bowel disease (Crohn's disease and ulcerative colitis) can cause chronic monocyte elevation 3
  • Chronic inflammatory conditions trigger monocyte expansion through persistent cytokine stimulation 2, 4
  • Atherosclerosis and coronary artery disease are associated with elevated monocyte counts, as monocytes play a pathogenic role in plaque formation 4
  • Tissue injury and chronic inflammation of any cause can lead to monocytosis 4, 5

Clonal Causes

  • CMML is the primary hematologic malignancy causing persistent monocytosis and requires specific diagnostic criteria 1
  • WHO 2008 criteria for CMML include persistent peripheral blood monocytosis (>1×10⁹/L), absence of Philadelphia chromosome or BCR-ABL1 fusion gene, and <20% blasts in blood and bone marrow 1
  • Molecular mutations commonly found in CMML include TET2, SRSF2, ASXL1, and RAS 1

Diagnostic Approach

  • Persistent monocytosis without clear reactive cause mandates bone marrow evaluation 1
  • Absolute monocyte count >1×10⁹/L that persists beyond 3 months requires hematologic workup 1
  • Essential workup includes complete blood count with differential, peripheral blood smear examination, and bone marrow aspiration and biopsy with conventional cytogenetics 1
  • Molecular testing for BCR-ABL1 and mutations in TET2, SRSF2, ASXL1, and RAS genes is necessary 1